male
oral pilsicainide
sodium channel blocker
slow recovery
kinetics
paroxysmal
atrial fibrillation
sinus rhythm
patient
sudden cardiac death
days
Holter electrocardiogram
worn
torsade de pointes
prolonged
QT intervals
drug
gastrointestinal tract
excreted
kidney
patient's
renal function
impaired
dose
pilsicainide
low
plasma
concentration
pilsicainide
torsades de pointes
octogenarian
oral administration
class IC drugs
pilsicainide
effective
atrial fibrillation
drugs
octogenarians
